Literature DB >> 19060121

Cardiovascular responses to microinjections of urocortin 3 into the nucleus tractus solitarius of the rat.

Takeshi Nakamura1, Kazumi Kawabe, Hreday N Sapru.   

Abstract

Urocortin 3 (Ucn3) is a new member of the corticotropin-releasing factor (CRF) peptide family and is considered to be a specific and endogenous ligand for CRF type 2 receptors (CRF2Rs). The presence of CRF(2)Rs has been reported in the nucleus tractus solitarius (NTS) of the rat. It was hypothesized that the activation of CRF2Rs in the medial NTS (mNTS) may play a role in cardiovascular regulation. This hypothesis was tested in urethane-anesthetized, artificially ventilated, adult male Wistar rats. Microinjections (100 nl) of Ucn3 (0.03, 0.06, 0.12, and 0.25 mM) into the mNTS of anesthetized rats elicited decreases in mean arterial pressure (MAP: 5.0 +/- 1.0, 21.6 +/- 2.6, 20.0 +/- 2.8, and 12.7 +/- 3.4 mmHg, respectively) and heart rate (HR: 7.8 +/- 2.6, 46.2 +/- 9.3, 34.5 +/- 8.4, and 16.6 +/- 4.9 beats/min, respectively). Microinjections of artificial cerebrospinal fluid (100 nl) into the mNTS did not elicit cardiovascular responses. Maximum decreases in MAP and HR were elicited by 0.06 mM concentration of Ucn3. Cardiovascular responses to Ucn3 were similar in unanesthetized midcollicular decerebrate rats. A bilateral vagotomy completely abolished Ucn3-induced bradycardia. The decreases in MAP and HR elicited by Ucn3 (0.06 mM) were completely blocked by astressin (1 mM; nonselective CRFR antagonist) and K41498 (5 mM; selective CRF2R antagonist). Microinjections of Ucn3 (0.06 mM) into the mNTS decreased the efferent greater splanchnic nerve activity. After the blockade of CRF2Rs in the mNTS, a Ucn3-induced decrease in the efferent sympathetic nerve discharge was abolished. These results indicate that Ucn3 microinjections into the mNTS exerted excitatory effects on the mNTS neurons via CRF2Rs, leading to depressor and bradycardic responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060121      PMCID: PMC2643898          DOI: 10.1152/ajpheart.01044.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  44 in total

Review 1.  Corticotropin releasing factor receptors and their ligand family.

Authors:  M H Perrin; W W Vale
Journal:  Ann N Y Acad Sci       Date:  1999-10-20       Impact factor: 5.691

2.  Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.

Authors:  Chien Li; Joan Vaughan; Paul E Sawchenko; Wylie W Vale
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 3.  International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands.

Authors:  Richard L Hauger; Dimitri E Grigoriadis; Mary F Dallman; Paul M Plotsky; Wylie W Vale; Frank M Dautzenberg
Journal:  Pharmacol Rev       Date:  2003-03       Impact factor: 25.468

4.  Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius.

Authors:  P M Gross; K M Wall; J J Pang; S W Shaver; D S Wainman
Journal:  Am J Physiol       Date:  1990-12

5.  Noradrenergic inhibitory modulation in the caudal commissural NTS of the pressor response to chemoreflex activation in awake rats.

Authors:  Luciana C Silva de Oliveira; Leni G H Bonagamba; Benedito H Machado
Journal:  Auton Neurosci       Date:  2007-05-18       Impact factor: 3.145

6.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.

Authors:  K Lewis; C Li; M H Perrin; A Blount; K Kunitake; C Donaldson; J Vaughan; T M Reyes; J Gulyas; W Fischer; L Bilezikjian; J Rivier; P E Sawchenko; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

7.  Stimulation of NTS activates NMDA and non-NMDA receptors in rat cardiac vagal neurons in the nucleus ambiguus.

Authors:  R A Neff; M Mihalevich; D Mendelowitz
Journal:  Brain Res       Date:  1998-05-11       Impact factor: 3.252

8.  Cardiovascular actions of adrenocorticotropin microinjections into the nucleus tractus solitarius of the rat.

Authors:  S Brown; V C Chitravanshi; H N Sapru
Journal:  Neuroscience       Date:  2006-09-25       Impact factor: 3.590

9.  Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

Authors:  T M Reyes; K Lewis; M H Perrin; K S Kunitake; J Vaughan; C A Arias; J B Hogenesch; J Gulyas; J Rivier; W W Vale; P E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

10.  Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain.

Authors:  M M Sánchez; L J Young; P M Plotsky; T R Insel
Journal:  J Comp Neurol       Date:  1999-06-07       Impact factor: 3.215

View more
  10 in total

1.  Cardiovascular responses elicited by a new endogenous angiotensin in the nucleus tractus solitarius of the rat.

Authors:  Vineet C Chitravanshi; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

2.  The hypothalamic arcuate nucleus: a new site of cardiovascular action of angiotensin-(1-12) and angiotensin II.

Authors:  Hideki Arakawa; Vineet C Chitravanshi; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-24       Impact factor: 4.733

3.  Bradycardic effects of microinjections of urocortin 3 into the nucleus ambiguus of the rat.

Authors:  Vineet C Chitravanshi; Kazumi Kawabe; Hreday N Sapru
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-09-26       Impact factor: 3.619

4.  Microinjections of urocortin1 into the nucleus ambiguus of the rat elicit bradycardia.

Authors:  Vineet C Chitravanshi; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-15       Impact factor: 4.733

5.  CRHR2 (Corticotropin-Releasing Hormone Receptor 2) in the Nucleus of the Solitary Tract Contributes to Intermittent Hypoxia-Induced Hypertension.

Authors:  Lei A Wang; Dianna H Nguyen; Steve W Mifflin
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

6.  Muscimol microinjection into cerebellar fastigial nucleus exacerbates stress-induced gastric mucosal damage in rats.

Authors:  Jin-zhou Zhu; Su-juan Fei; Jian-fu Zhang; Sheng-ping Zhu; Zhang-bo Liu; Ting-ting Li; Xiao Qiao
Journal:  Acta Pharmacol Sin       Date:  2012-12-17       Impact factor: 6.150

7.  Mechanisms of cardiovascular actions of urocortins in the hypothalamic arcuate nucleus of the rat.

Authors:  Vineet C Chitravanshi; Kazumi Kawabe; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-17       Impact factor: 4.733

8.  Cardiovascular responses to microinjections of urocortins into the NTS: role of inotropic glutamate receptors.

Authors:  Takeshi Nakamura; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-24       Impact factor: 4.733

9.  Protective effect of histamine microinjected into the cerebellar fastigial nucleus on stress-induced gastric mucosal damage in rats.

Authors:  Xiao Qiao; Xiaolong Tang; Jianfu Zhang; Ke Chen; Yanming Zhang; Changcheng Wang; Sujuan Fei; Jinzhou Zhu; Shengping Zhu; Zhangbo Liu; Tingting Li; Shengxiang Lv; Yong Liang
Journal:  Am J Transl Res       Date:  2015-09-15       Impact factor: 4.060

10.  Corticotropin releasing factor excites neurons of posterior hypothalamic nucleus to produce tachycardia in rats.

Authors:  He-Ren Gao; Qian-Xing Zhuang; Bin Li; Hong-Zhao Li; Zhang-Peng Chen; Jian-Jun Wang; Jing-Ning Zhu
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.